Literature DB >> 2428572

[Comparison of CHOP and COP-BLAM chemotherapy in highly malignant non-Hodgkin's lymphoma].

H H Gerhartz, E Thiel, E Hiller, C Nerl, W Wilmanns, D Huhn.   

Abstract

The course of disease in 61 consecutive patients with non-Hodgkin lymphoma of high grade malignancy, treated between 1979 and 1985 with either CHOP or COP-BLAM regimen, was analysed retrospectively. Both groups showed a highly similar distribution of prognostic variables. COP-BLAM treatment resulted in significantly more complete remissions (23 of 27) than CHOP (11 of 29, P = 0.001). Life expectancy was, therefore, considerably higher in the COP-BLAM treated group. The mean observation period, however, was longer for CHOP-treated patients (37 vs. 30 months. The higher remission rate of the COP-BLAM regimen was not compromised by a substantial increase in toxicity; no therapy-related death was observed. Thus, the COP-BLAM regimen appears to be superior in inducing complete remissions in aggressive non-Hodgkin lymphoma. Actual survival curves suggest that this corresponds to an increased proportion of cured patients, but longer follow-ups are needed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428572     DOI: 10.1055/s-2008-1068662

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.

Authors:  H H Gerhartz; E Thiel; G Brittinger; B Dörken; M Engelhard; W Engert; W Enne; R Fuchs; C H Hagen-Aukamp; D Huhn
Journal:  Blut       Date:  1988-03

2.  Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy.

Authors:  R Heinz
Journal:  Blut       Date:  1990-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.